Skip to main content
. 2024 Feb 14;15:1367. doi: 10.1038/s41467-024-45561-z

Fig. 8. Schema of epigenetic regulation of NK cell-mediated immune response in multiple myeloma monoclonal antibody therapy.

Fig. 8

The loss or inactivation of KDM6A increased the level of H3K27me3, resulting in the downregulation of both CD38 and CD48 expression, which led to reduced ADCC. Lowering the H3K27me3 with an EZH2 inhibitor restored sensitivity to Dara through CD38 and CD48 upregulation. This Figure was created with BioRender.com.